Pharmaceuticals
Healthcare
Dr Reddy's recalls some lots of heartburn drug in US
Generic drugmaker Dr. Reddy's Laboratories Ltd is recalling about 58,656 bottles of the heartburn drug lansoprazole in the United States ......
Healthcare
Big Pharma still betting on "messed up" Indian drugs market
Global drugmakers have had a nauseous time in India's $14 billion market. Prices have dropped and valuable patents have been ......
Healthcare
Glaxo completes $1B open offer to raise stake in Indian pharma arm to 75%
British pharmaceutical giant GlaxoSmithKline Plc (GSK) has completed its voluntary open offer for the Indian pharma arm, spending around Rs ......
Healthcare
Sun Pharma eyes partnerships, acquisitions to enter Japanese market
Sun Pharmaceuticals Industries Ltd, the country’s largest drugmaker by market capitalisation, is exploring opportunities to partner or acquire companies in ......
Healthcare
AstraZeneca seeks to delist Indian arm
British-Swedish pharmaceutical firm AstraZeneca has made a voluntarily open offer to delist the Indian arm AstraZeneca Pharma India Ltd, according ......
Healthcare
HLL Lifecare acquires majority stake in Goa Antibiotics
HLL Lifecare Limited (HLL), a mini ratna public sector enterprise, has acquired 74 per cent stake in Goa Antibiotics and ......
Healthcare
Ranbaxy suspends shipment of drugs from two plants
Indian drug major Ranbaxy Laboratories Ltd has announced that it has temporarily suspended shipment from its two active pharmaceutical ingredients ......
Healthcare
GSK Pharma's $1B open offer starts on Tuesday
UK-based GlaxoSmithKline Plc’s (GSK) open offer to raise its holding in its Indian arm GlaxoSmithKline Pharmaceuticals Ltd from 50.7 per ......
Healthcare
India's pharma sales to reach $27B by 2016: Deloitte report
Despite challenges like drug price control, poor healthcare infrastructure, quality management and meeting global standards, Indian pharmaceutical sector will see ......
Healthcare
Teva, Ranbaxy settle claims in US over collusion
The New York Attorney General and the U.S. units of Ranbaxy Laboratories and Teva Pharmaceutical Industries have settled claims that ......